Literature DB >> 8016807

Sauna builder's asthma caused by obeche (Triplochiton scleroxylon) dust.

K Reijula1, V Kujala, J Latvala.   

Abstract

Two carpenters developed rhinitis, conjunctivitis, bronchial wheezing, and dyspnoea while using obeche (Triplochiton scleroxylon, African maple) at their work while they built saunas. Skin prick tests showed an immediate reaction, specific IgE to obeche was detected in their serum, and bronchial provocation test with obeche gave an immediate reaction with decrease of FEV1 and PEF values. The symptoms disappeared after avoiding the use of obeche. Obeche may cause a health hazard to carpenters who are exposed to this dust and who may develop allergic symptoms after the exposure.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8016807      PMCID： PMC474974          DOI： 10.1136/thx.49.6.622

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  Laboratory animal allergy in a pharmaceutical company.

Authors:  K M Venables; R D Tee; E R Hawkins; D J Gordon; C J Wale; N M Farrer; T H Lam; P J Baxter; A J Newman Taylor
Journal:  Br J Ind Med       Date:  1988-10

Review 2.  Respiratory health effects from occupational exposure to wood dusts.

Authors:  D F Goldsmith; C M Shy
Journal:  Scand J Work Environ Health       Date:  1988-02       Impact factor: 5.024

3.  Asthma caused by African maple (Triplochiton scleroxylon) wood dust.

Authors:  M Hinojosa; I Moneo; J Dominguez; E Delgado; E Losada; R Alcover
Journal:  J Allergy Clin Immunol       Date:  1984-12       Impact factor: 10.793

4.  Bronchial hyperresponsiveness and level of exposure in occupational asthma due to western red cedar (Thuja plicata). Serial observations before and after development of symptoms.

Authors:  M Chan-Yeung; A Desjardins
Journal:  Am Rev Respir Dis       Date:  1992-12
  4 in total
  1 in total

1.  Antigenic proteins involved in occupational rhinitis and asthma caused by obeche wood (Triplochiton scleroxylon).

Authors:  Ana Aranda; Paloma Campo; Arantxa Palacin; Inmaculada Doña; Cristina Gomez-Casado; Luisa Galindo; Araceli Díaz-Perales; Miguel Blanca
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.